The Readout Loud

324 Episodes

1. Episode 163: Marilynn Marchione on covering the CRISPR babies scandal

   Published: 03/06/2021
2. Episode 162: Scott Gottlieb on Covid and grilling, plus how Zolgensma has changed SMA

   Published: 27/05/2021
3. Episode 161: Biotech meme stocks, the lessons of Spanish Flu, & becoming a pandemic celebrity

   Published: 20/05/2021
4. Episode 160: Global Covid-19 failures, a sluggish CDC, and a boisterous STAT Health Tech Summit

   Published: 13/05/2021
5. Episode 159: Thomas Bollyky on patent waivers, plus vaccine riches, & a gene therapy for aging

   Published: 06/05/2021
6. Episode 158: Angela Rasmussen on Russia's vaccine controversy, plus Biden's drug pricing punt

   Published: 29/04/2021
7. Episode 157: Mercedes Carnethon on outdoor masking, FDA in limbo, & gene therapy's uncertain upside

   Published: 22/04/2021
8. Episode 156: J&J's vaccine pause, talking about remote risks, & why no new drugs for Covid-19

   Published: 15/04/2021
9. Episode 155: AstraZeneca's vaccine woes, compassionate use, & giving out Covid vaccines

   Published: 08/04/2021
10. Episode 154: Eleanor Fox on Illumina’s FTC headache, plus Talkspace’s experiment

    Published: 01/04/2021
11. Episode 153: AstraZeneca and the very good, then quite bad, then deeply confusing week

    Published: 25/03/2021
12. Episode 152: Alison Buttenheim on Europe's vaccine scare, Lilly's Alzheimer's data, & a PR plea

    Published: 18/03/2021
13. Episode 151: Natasha Loder on Covid vaccines, the demise of Watson Health, and a 'synbio' explainer

    Published: 11/03/2021
14. Episode 150: Ashish Jha on Covid-19 optimism, plus pharma cooperation, & the next pandemic phase

    Published: 04/03/2021
15. Episode 149: Nancy Goodman on Covid vaccines for kids, & Greg Zuckerman on Novavax's remarkable rise

    Published: 25/02/2021
16. Episode 148: Akshay Sharma on gene therapy's setback, biotech's brashest VCs, & the FDA's future

    Published: 18/02/2021
17. Episode 147: David Fajgenbaum on Covid-19 drugs, the state of the pandemic, & meme biotech stocks

    Published: 11/02/2021
18. Episode 146: Paul Offit on vaccine data, 23andMe is going public, & Merck's CEO is retiring

    Published: 04/02/2021
19. Episode 145: Kevin Davies on the CRISPR boom, & Megan Ranney on scientific misinformation

    Published: 28/01/2021
20. Episode 144: Remembering STAT's Sharon Begley

    Published: 22/01/2021